Compare AOUT & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AOUT | TVGN |
|---|---|---|
| Founded | 2020 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ordnance And Accessories | Blank Checks |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 99.7M | 63.9M |
| IPO Year | 2020 | N/A |
| Metric | AOUT | TVGN |
|---|---|---|
| Price | $8.13 | $5.28 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | ★ $12.50 | N/A |
| AVG Volume (30 Days) | 37.3K | ★ 477.4K |
| Earning Date | 03-12-2026 | 04-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 98.94 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $222,322,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $8.24 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 10.55 | N/A |
| 52 Week Low | $6.26 | $0.14 |
| 52 Week High | $13.73 | $10.76 |
| Indicator | AOUT | TVGN |
|---|---|---|
| Relative Strength Index (RSI) | 36.70 | 65.35 |
| Support Level | $6.40 | $0.53 |
| Resistance Level | $8.91 | $10.76 |
| Average True Range (ATR) | 0.45 | 0.87 |
| MACD | -0.11 | 0.18 |
| Stochastic Oscillator | 17.78 | 46.97 |
American Outdoor Brands Inc is engaged in the business of providing outdoor products and accessories for hunting, fishing, camping, shooting, and personal security and defense products. The company designs and produces products and accessories, including shooting supplies, rest, vaults, and other related accessories; premium sportsman knives and tools for fishing and hunting; land management tools for hunting preparedness; harvesting products for post-hunt or post-fishing activities; electro-optical devices, including hunting optics, firearm aiming devices, flashlights, and laser grips; reloading, gunsmithing, and firearm cleaning supplies; and survival, camping, and emergency preparedness products.
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.